- Tytuł:
- AML-295 AGILE: A Global, Randomized, Double-Blind, Phase 3 Study of Ivosidenib + Azacitidine Versus Placebo + Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 Mutation
- Autorzy:
- Źródło:
- In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S234-S234
Czasopismo naukowe